Title of article
Effect of Bromocriptine Mesylate as Add-On Therapy in Obese Type 2 Diabetes Mellitus Patients
Author/Authors
Dhore، Rajendra نويسنده MBBS, M.D. (Medicine) Associate Professor, Department of Medicine. Dr. Panjabrao Deshmukh Medical College, Amravati Maharashtra , India , , Dhore، Akshay نويسنده M.D. (Medicine) P.G. Student Department of Medicine, Netaji Shubash Chandra Bosh ,Government Medical College, Jabalpur, Madhya. Pradesh , India , , Wasnik، Vinod نويسنده MBBS, M.D. (PSM) Associate Professor, Department of Community Medicine. Dr. Panjabrao Deshmukh .Medical College, Amravati Maharashtra ,India , , Jadhav، Nilesh نويسنده PG Student (MD Medicine) Department of Medicine. Dr. Panjabrao Deshmukh .Medical College, Amravati Maharashtra ,India ,
Issue Information
فصلنامه با شماره پیاپی 0 سال 2013
Pages
3
From page
88
To page
90
Abstract
Six months administration of bromocriptine mesylate significantly decreased glycated hemoglobin (HbA1c), fasting blood sugar, postprandial blood sugar, and weight of 22 Indian obese patients with type 2 diabetes mellitus with no serious adverse events. Therefore, the novel mechanism of action, efficacy and acceptable safety profile makes this drug an attractive option for treatment of obese type 2 diabetic patients
Journal title
Iranian Journal of Diabetes and Obesity
Serial Year
2013
Journal title
Iranian Journal of Diabetes and Obesity
Record number
1088032
Link To Document